Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter studyMaël Heiblig, Pierre Sujobert, Marcela A. Ferrada et al.|Blood|2022Cited by 212
Spectrum of clonal hematopoiesis in VEXAS syndromeFernanda Gutierrez‐Rodrigues, Mrinal M. Patnaik, Kenneth J. Warrington et al.|Blood|2023Cited by 106
Venous and arterial thrombosis in patients with VEXAS syndromeYael Kusne, Emma M. Groarke, Atefeh Ghorbanzadeh et al.|Blood|2024Cited by 55
Clinical Efficacy of JAK Inhibitors in Patients with Vexas Syndrome: A Multicenter Retrospective StudyMaël Heiblig, Pierre Sujobert, Marcela A. Ferrada et al.|Blood|2021Cited by 12
Clonal Hematopoiesis in Vexas SyndromeBhavisha A. Patel, Neal S. Young, Fernanda Gutierrez‐Rodrigues et al.|Blood|2022Cited by 6